Product Information
ZOLPIDEM TART 1.75 MG TAB SL is a generic product labeled by Endo USA Inc., priced at $5.0457 per EA under NDC 49884089811. Its NADAC has been published 168 times since Jul 19, 2023.
FDA first approved this application on Sep 11, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.75 mg/1
Manufacturer
Endo USA Inc.NDC
49884089811
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
ZOLPIDEM TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA204229FDA Approved
9/11/2017
TE Code
AB
On Market Since
9/11/2017
Pharmacological Classes
Price Statistics
The NADAC for ZOLPIDEM TART 1.75 MG TAB SL has been published 168 times since Jul 19, 2023, and over the history we have for it it has risen 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.0457 per EA |
|---|---|
| All-time high | $5.8033 (Jan 10, 2024) |
| All-time low | $4.4763 (Jul 17, 2024) |
| 52-week high | $5.5629 |
| 52-week low | $5.0457 |
| Median price | $5.1395 |
| Average price | $5.1256 |
| Largest weekly change | +23.0% (Dec 20, 2023) |
| Weeks tracked | 168 |
| Tracking since | Jul 19, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Zolpidem tartrate sublingual market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolpidem tartrate sublingual market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid A Receptor Positive Modulator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOLPIDEM TART 1.75 MG TAB SL?
The current National Average Drug Acquisition Cost (NADAC) for ZOLPIDEM TART 1.75 MG TAB SL, manufactured by Endo USA Inc., is $5.0457 per EA (NDC 49884089811), effective Sep 30, 2026.
How has the price of ZOLPIDEM TART 1.75 MG TAB SL changed over time?
Over the history we have for it, the NADAC for ZOLPIDEM TART 1.75 MG TAB SL has risen 6.9%. It has been tracked across 168 weekly CMS publications since Jul 19, 2023.
What are the highest and lowest recorded NADAC prices for ZOLPIDEM TART 1.75 MG TAB SL?
Since Jul 19, 2023, the NADAC for ZOLPIDEM TART 1.75 MG TAB SL has ranged from a low of $4.4763 (Jul 17, 2024) to a high of $5.8033 (Jan 10, 2024), with a median of $5.1395 per EA.
Are there cheaper alternatives to ZOLPIDEM TART 1.75 MG TAB SL?
No other NADAC-published product currently shares the active ingredient and strength of ZOLPIDEM TART 1.75 MG TAB SL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZOLPIDEM TART 1.75 MG TAB SL?
ZOLPIDEM TART 1.75 MG TAB SL (NDC 49884089811) is labeled by Endo USA Inc., and CMS classifies it as a generic product.